Obesity drugs would be covered by Medicare and Medicaid under Biden administration proposal
Nov 26, 2024
About 7 million people enrolled in Medicare and Medicaid would gain access to weight-loss drugs like Ozempic, Wegovy, Zepbound and Mounjaro, which are not covered by these federal programs, under a new Biden administration proposal. But it will need to be finalized by the Trump administration.
https://www.phillyvoice.com/weight-loss-drugs-medicare-medicaid-coverage-obesity-ozempic-zepbound/?utm_source=pv-rss&utm_medium=rss&utm_campaign=pv-site
Respond, make new discussions, see other discussions and customize your news...

To add this website to your home screen:

1. Tap tutorialsPoint

2. Select 'Add to Home screen' or 'Install app'.

3. Follow the on-scrren instructions.

Feedback
FAQ
Privacy Policy
Terms of Service